New pill tested to tame debilitating hormone disorder
NCT ID NCT03774446
Summary
This study is testing whether a 4-week course of an oral drug called seliciclib is safe and can help control the excess hormone production in adults with Cushing disease. It will involve about 13 people whose disease is newly diagnosed, has come back, or didn't go away after previous treatment. Researchers will measure hormone levels and check for side effects to see if the drug helps manage the condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.